Related Blog Entries

• Pfizer settles Bextra, Celebrex personal injury lawsuits
• Merck extends registration deadline in settlement for former users of Vioxx
• Unsealed Lipitor lawsuit alleges defective marketing
• Study finds aspirin-resistant patients more prone to suffer heart attack, stroke
• Family hits GlaxoSmithKline with Avandia wrongful death lawsuit
• JAMA study also says Avandia causes heart attack
• Texas Vioxx Jurors did not accept Merck’s arguments
• Vioxx Widow Awarded $253.4 Million
• First federal Vioxx trial scheduled
• Celebrex label revised yet again
• Judge rules health plans can sue over Vioxx prescription costs
• Ortho Evra linked to strokes and blood clots
• Deaths from Ortho Evra patch
• Ortho-McNeil facing seven product-liability suits
• Texas sues Merck over Vioxx
• Medtronic did not fix defibrillator flaws
• Merck sought combo drug to lessen Vioxx risk
• Merck pressured doctors to refrain from discussing Vioxx safety concerns
• Ephedra Dietary Supplement Removed from Market
• Guidant hid Ventak Prizm 2 flaw
• Zyprexa, Seroquel linked to rise in elderly deaths
• FDA Requests Bextra Withdrawal
• COX-2 Drugs May Suppress Immune Function
• Avandia carries black box warning of risk of heart attack, chest pain
• Merck allots $4.85 billion to settle Vioxx lawsuits
• Celebrex 3.6 times more likely to cause heart attack in Alzheimer’s patients
• Study linking Vioxx to heart problems finally published
• Welch Allyn recalls external defibrillators because of failures, delays in devices
• Researchers can’t explain link between Pfizer’s torcetrapib and heart attacks, death
• Trasylol pulled from U.S. market
• UNC doctor says GlaxoSmithKline threatened to sue him over Avandia criticism
• UNC diabetes expert to testify at congressional hearing on Avandia
• Study finds diabetes drug Avandia may raise risk for heart attack, death
• Public Citizen alleges FDA knew of Avandia dangers in 2002
• Questions and Answers about diabetes drug Avandia
• Professor testifies GSK trials of Avandia about marketing, not safety
• Patients start to file cases against Avandia
• Ortho suit filed in embolism case
• Ortho Evra makers sued over blood clots
• Ortho Evra label updated for risk of clots
• New Study criticizes Ortho patch
• Lawsuit filed against Ortho-McNeil on behalf of woman who suffered pulmonary embolism while on Ortho Evra patch
• Johnson & Johnson Faces Thousands of Ortho Evra Lawsuits
• Congressmen concerned about Avandia risks
• Chapel Hill doctor warned FDA of Avandia concerns in 2000
• FDA wants ‘black box’ warning on Avandia
• FDA reprimands its own scientist for Avandia warning
• FDA receives triple Avandia reports after study
• German doctors say Avandia is more dangerous than alternatives
• FDA Updates Labeling for Ortho Evra Contraceptive Patch
• Avandia researcher says drug is ‘paradox’ with no established health benefits
• 43-women file Ortho Evra patch lawsuits after serious health problems
• Medicare Continues to Deny Reimbursement for Anemia Drugs
• Deaths among Aricept patients
• Scientists: Why Vioxx caused heart problems
• FDA adds black box warning to Avandia, diabetes drugs
• Eli Lilly to seek approval for experimental heart drug Prasugrel
• FDA concludes Nexium, Prilosec don’t increase heart attacks
• Death of heart bypass surgery patient raised questions about Bayer’s Trasylol
• FDA approves AIDS drug Selzentry despite serious side effects
• Fed panel wants stricter ADHD drug labels
• Study cautions against possible Novartis drug combo
• Public Citizen alleges FDA knew of Avandia dangers in 2002
• Glaxo says drug is safe, despite study
• Iowa man sues Bextra manufacturer over his stroke
• Pfizer agrees to suspend Celebrex advertising
• Oxford study says Vioxx causes heart problems earlier than company claimed
• Oxford study says Vioxx causes heart problems earlier than company claimed
• Man accepts $1.6 million in Vioxx settlement